|STADA Arzneimittel Aktiengesellschaft -- USA Stock|| |
USD 104.04 0.00 0.00%
Member of the Supervisory Board
Mr. Dieter Koch was Member of the Supervisory Board at STADA Arzneimittel AG from 1983 to August 26 2016. He served as Member of the Human Resources Committee at the Company. From 1966 to 1990 he was Managing Director of SonnenApotheke in Germany and from 1975 to 1990 served as Chairman of the Examination Board for Pharmacy Assistants. He was previously the Deputy Chairman of the Employers Association of German Pharmacies. From 1970 to 1983 he was a Member of the Advisory Board at STADA Arzneimittel AG. He studied pharmacy in Kiel Germany.
Age: 78 Executive Since 1983
49 6101 603 0 http://www.stada.de
The company has return on total asset (ROA)
of 5.26 %
which means that it generated profit of $5.26 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 9.8 %
meaning that it generated $9.8 on every $100 dollars invested by stockholders.
The company has accumulated 1.77 B in total debt with debt to equity ratio (D/E) of 134.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. STADA Arzneimittel Aktiengesellschaft has Current Ratio of 0.67 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
|Found 1 records|
|Chris Suh||Microsoft Corporation|
STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. STADA Arzneimittel Aktiengesellschaft was founded in 1895 and is headquartered in Bad Vilbel, Germany. STADA Arzneimittel is traded on OTC Market in USA.STADA Arzneimittel Aktiengesellschaft (STDAF) is traded on OTC Market in USA. It is located in Stadastrasse 2-18 and employs 11,117 people.